These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10978184)

  • 1. Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.
    Annoura H; Nakanishi K; Toba T; Takemoto N; Imajo S; Miyajima A; Tamura-Horikawa Y; Tamura S
    J Med Chem; 2000 Sep; 43(18):3372-6. PubMed ID: 10978184
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of in vitro and in vivo acute ischemic neuronal damage by (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl) phenyl]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075), a novel neuroprotective agent with antioxidant properties.
    Kotani Y; Morimoto N; Oida Y; Tamura Y; Tamura S; Inoue T; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neuroscience; 2007 Nov; 149(4):779-88. PubMed ID: 17945433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na(+) and Ca(2+) channel blockers with reduced affinity for dopamine D(2) receptors.
    Annoura H; Nakanishi K; Uesugi M; Fukunaga A; Imajo S; Miyajima A; Tamura-Horikawa Y; Tamura S
    Bioorg Med Chem; 2002 Feb; 10(2):371-83. PubMed ID: 11741786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties.
    Hu LY; Ryder TR; Rafferty MF; Feng MR; Lotarski SM; Rock DM; Sinz M; Stoehr SJ; Taylor CP; Weber ML; Bowersox SS; Miljanich GP; Millerman E; Wang YX; Szoke BG
    J Med Chem; 1999 Oct; 42(20):4239-49. PubMed ID: 10514294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonists.
    Ryder TR; Hu LY; Rafferty MF; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2453-8. PubMed ID: 10476886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel series of 2,6,7-substituted 2,3-dihydro-1,4-benzodioxin and 2,6,7-substituted 1,4-benzodioxin derivatives as lipid peroxidation inhibitors. Structure-activity relationships for high inhibition of human low-density lipoprotein peroxidation.
    Thiéry V; Coudert G; Bizot-Espiard JG; Pfeiffer B; Renard P; Lindenbaum A; Guillaumet G
    J Med Chem; 2001 Nov; 44(23):3904-14. PubMed ID: 11689076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.
    Maillard MC; Perlman ME; Amitay O; Baxter D; Berlove D; Connaughton S; Fischer JB; Guo JQ; Hu LY; McBurney RN; Nagy PI; Subbarao K; Yost EA; Zhang L; Durant GJ
    J Med Chem; 1998 Jul; 41(16):3048-61. PubMed ID: 9685245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects.
    Annoura H; Nakanishi K; Uesugi M; Fukunaga A; Miyajima A; Tamura-Horikawa Y; Tamura S
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2999-3002. PubMed ID: 10571163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
    Oyagi A; Oida Y; Hara H; Izuta H; Shimazawa M; Matsunaga N; Adachi T; Hara H
    Brain Res; 2008 Jun; 1214():169-76. PubMed ID: 18457816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia.
    Hu LY; Ryder TR; Rafferty MF; Taylor CP; Feng MR; Kuo BS; Lotarski SM; Miljanich GP; Millerman E; Siebers KM; Szoke BG
    Bioorg Med Chem; 2000 Jun; 8(6):1203-12. PubMed ID: 10896101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VGF and striatal cell damage in in vitro and in vivo models of Huntington's disease.
    Noda Y; Shimazawa M; Tanaka H; Tamura S; Inoue T; Tsuruma K; Hara H
    Pharmacol Res Perspect; 2015 Jun; 3(3):e00140. PubMed ID: 26171223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities.
    Kimura M; Masuda T; Yamada K; Kubota N; Kawakatsu N; Mitani M; Kishii K; Inazu M; Namiki T
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1947-50. PubMed ID: 12113815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents.
    Reddy NL; Fan W; Magar SS; Perlman ME; Yost E; Zhang L; Berlove D; Fischer JB; Burke-Howie K; Wolcott T; Durant GJ
    J Med Chem; 1998 Aug; 41(17):3298-302. PubMed ID: 9703475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1H)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity.
    Bebbington D; Monck NJ; Gaur S; Palmer AM; Benwell K; Harvey V; Malcolm CS; Porter RH
    J Med Chem; 2000 Jul; 43(15):2779-82. PubMed ID: 10956184
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
    Benes J; Parada A; Figueiredo AA; Alves PC; Freitas AP; Learmonth DA; Cunha RA; Garrett J; Soares-da-Silva P
    J Med Chem; 1999 Jul; 42(14):2582-7. PubMed ID: 10411478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and bio-activity evaluation of tetraphenyl(phenylamino) methylene bisphosphonates as antioxidant agents and as potent inhibitors of osteoclasts in vitro.
    Balakrishna A; Narayana Reddy MV; Rao PV; Kumar MA; Kumar BS; Nayak SK; Reddy CS
    Eur J Med Chem; 2011 May; 46(5):1798-802. PubMed ID: 21397367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of anticonvulsant properties of new N-Mannich bases derived from 3-(1-phenylethyl)- and 3-benzyl-pyrrolidine-2,5-dione.
    Rybka S; Obniska J; Rapacz A; Furgała A; Filipek B; Żmudzki P
    Bioorg Med Chem Lett; 2016 May; 26(9):2147-51. PubMed ID: 27032334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of 2-(4-benzhydryl-1-piperazinyl)-1-phenylethanols as new calcium blockers.
    Nomura Y; Yamakawa T; Nishioka K; Omura T; Miyake N; Masaki M; Nohira H
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):241-6. PubMed ID: 7537178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia.
    O'Neill MJ; Hicks CA; Ward MA; Osborne DJ; Wishart G; Mathews KS; McLaughlin DP; Stamford JA; McCarty DR; Patrick KE; Roman C; Fleisch JH; Gilmore J; Boot JR
    Brain Res; 2001 Jan; 888(1):138-149. PubMed ID: 11146060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.